C150H150F20N32O16 — CID 157066680
N-[6-[4-[(2-fluorophenyl)carbamoyl]-2-methylphenyl]-3-pyridinyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[(2S)-4-[(2-fluorophenyl)carbamoyl]-2-methylpiperazin-1-yl]-3-pyridinyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[(3R)-4-[(2-fluorophenyl)carbamoyl]-3-methylpiperazin-1-yl]-3-pyridinyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[5-[4-[(2-fluorophenyl)carbamoyl]piperazin-1-yl]-2-pyridinyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[(3R)-1-[(2-fluorophenyl)carbamoyl]pyrrolidin-3-yl]oxy-3-pyridinyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide (PubChem CID 157066680) has the molecular formula C150H150F20N32O16 and a molecular weight of 3037.02 g/mol. Its IUPAC name is N-[6-[4-[(2-fluorophenyl)carbamoyl]-2-methylphenyl]-3-pyridinyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[(2S)-4-[(2-fluorophenyl)carbamoyl]-2-methylpiperazin-1-yl]-3-pyridinyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[(3R)-4-[(2-fluorophenyl)carbamoyl]-3-methylpiperazin-1-yl]-3-pyridinyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[5-[4-[(2-fluorophenyl)carbamoyl]piperazin-1-yl]-2-pyridinyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[(3R)-1-[(2-fluorophenyl)carbamoyl]pyrrolidin-3-yl]oxy-3-pyridinyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide.
| Compound Name | N-[6-[4-[(2-fluorophenyl)carbamoyl]-2-methylphenyl]-3-pyridinyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[(2S)-4-[(2-fluorophenyl)carbamoyl]-2-methylpiperazin-1-yl]-3-pyridinyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[(3R)-4-[(2-fluorophenyl)carbamoyl]-3-methylpiperazin-1-yl]-3-pyridinyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[5-[4-[(2-fluorophenyl)carbamoyl]piperazin-1-yl]-2-pyridinyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[(3R)-1-[(2-fluorophenyl)carbamoyl]pyrrolidin-3-yl]oxy-3-pyridinyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide |
|---|---|
| PubChem CID | 157066680 |
| Molecular Formula | C150H150F20N32O16 |
| Molecular Weight | 3037.02 g/mol |
| Exact Mass | 3035.16 |
| IUPAC Name | N-[6-[4-[(2-fluorophenyl)carbamoyl]-2-methylphenyl]-3-pyridinyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[(2S)-4-[(2-fluorophenyl)carbamoyl]-2-methylpiperazin-1-yl]-3-pyridinyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[(3R)-4-[(2-fluorophenyl)carbamoyl]-3-methylpiperazin-1-yl]-3-pyridinyl]-2-(4-phenylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[5-[4-[(2-fluorophenyl)carbamoyl]piperazin-1-yl]-2-pyridinyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[6-[(3R)-1-[(2-fluorophenyl)carbamoyl]pyrrolidin-3-yl]oxy-3-pyridinyl]-2-(3-methylpiperidin-1-yl)-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide |
| SMILES | CC1CCCN(c2nc(C(F)(F)F)c(C(=O)Nc3ccc(N4CCN(C(=O)Nc5ccccc5F)CC4)cn3)o2)C1.CC1CCCN(c2nc(C(F)(F)F)c(C(=O)Nc3ccc(N4CCN(C(=O)Nc5ccccc5F)C[C@@H]4C)nc3)o2)C1.CC1CCCN(c2nc(C(F)(F)F)c(C(=O)Nc3ccc(O[C@@H]4CCN(C(=O)Nc5ccccc5F)C4)nc3)o2)C1.C[C@@H]1CN(c2ccc(NC(=O)c3oc(N4CCC(c5ccccc5)CC4)nc3C(F)(F)F)cn2)CCN1C(=O)Nc1ccccc1F.Cc1cc(C(=O)Nc2ccccc2F)ccc1-c1ccc(NC(=O)c2oc(N3CCC(c4ccccc4)CC3)nc2C(F)(F)F)cn1 |
| InChI | InChI=1S/C35H29F4N5O3.C33H33F4N7O3.C28H31F4N7O3.C27H29F4N7O3.C27H28F4N6O4/c1-21-19-24(32(45)42-29-10-6-5-9-27(29)36)11-13-26(21)28-14-12-25(20-40-28)41-33(46)30-31(35(37,38)39)43-34(47-30)44-17-15-23(16-18-44)22-7-3-2-4-8-22;1-21-20-43(17-18-44(21)31(46)40-26-10-6-5-9-25(26)34)27-12-11-24(19-38-27)39-30(45)28-29(33(35,36)37)41-32(47-28)42-15-13-23(14-16-42)22-7-3-2-4-8-22;1-17-6-5-11-38(15-17)27-36-24(28(30,31)32)23(42-27)25(40)34-19-9-10-22(33-14-19)39-13-12-37(16-18(39)2)26(41)35-21-8-4-3-7-20(21)29;1-17-5-4-10-38(16-17)26-35-23(27(29,30)31)22(41-26)24(39)34-21-9-8-18(15-32-21)36-11-13-37(14-12-36)25(40)33-20-7-3-2-6-19(20)28;1-16-5-4-11-37(14-16)26-35-23(27(29,30)31)22(41-26)24(38)33-17-8-9-21(32-13-17)40-18-10-12-36(15-18)25(39)34-20-7-3-2-6-19(20)28/h2-14,19-20,23H,15-18H2,1H3,(H,41,46)(H,42,45);2-12,19,21,23H,13-18,20H2,1H3,(H,39,45)(H,40,46);3-4,7-10,14,17-18H,5-6,11-13,15-16H2,1-2H3,(H,34,40)(H,35,41);2-3,6-9,15,17H,4-5,10-14,16H2,1H3,(H,33,40)(H,32,34,39);2-3,6-9,13,16,18H,4-5,10-12,14-15H2,1H3,(H,33,38)(H,34,39)/t;21-;17?,18-;;16?,18-/m.10.1/s1 |
| InChIKey | ABYLLCZHYMAJEO-PGUAECOTSA-N |
| XLogP | 30.63 |
| TPSA | 533.71 Ų |
| H-Bond Donors | 10 |
| H-Bond Acceptors | 34 |
| Rotatable Bonds | 29 |
| Heavy Atoms | 218 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3037.02 |
| LogP ≤ 5 | 30.63 |
| H-Bond Donors ≤ 5 | 10 |
| H-Bond Acceptors ≤ 10 | 34 |